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ho family GTPases are important regulators of epithelial
tight junctions (TJs); however, little is known about
how the GTPases themselves are controlled during TJ
assembly and function. We have identiﬁed and cloned a
canine guanine nucleotide exchange factor (GEF) of the Dbl
family of proto-oncogenes that activates Rho and associates
with TJs. Based on sequence similarity searches and immuno-
logical and functional data, this protein is the canine homo-
logue of human GEF-H1 and mouse Lfc, two previously
identiﬁed Rho-speciﬁc exchange factors known to associate
with microtubules in nonpolarized cells. In agreement with
these observations, immunoﬂuorescence of proliferating
R
 
MDCK cells revealed that the endogenous canine GEF-H1/Lfc
associates with mitotic spindles. Functional analysis based
on overexpression and RNA interference in polarized
MDCK cells revealed that this exchange factor for Rho
regulates paracellular permeability of small hydrophilic
tracers. Although overexpression resulted in increased size-
selective paracellular permeability, such cell lines exhibited a
normal overall morphology and formed fully assembled TJs as
determined by measuring transepithelial resistance and by
immunoﬂuorescence and freeze-fracture analysis. These
data indicate that GEF-H1/Lfc is a component of TJs and
functions in the regulation of epithelial permeability.
 
Introduction
 
Epithelial cells interact with each other and with the under-
lying extracellular matrix using molecular complexes composed
of transmembrane proteins and distinct sets of cytoplasmic
plaque proteins that serve as connections to the cytoskeleton.
These interactions allow epithelial cells to achieve their typical
spatial organization and cell surface polarity. Tight junctions
(TJs)* are the most apical of the intercellular junctions: they
regulate selective paracellular diffusion and restrict the inter-
mixing of apical and basolateral membrane components
(Cereijido et al., 2000; Schneeberger and Lynch, 2001). TJ
components have also been proposed to be linked to mecha-
nisms that control epithelial polarization and differentiation
(Tsukita et al., 1999; Zahraoui et al., 2000; Benais-Pont et
al., 2001; Fleming et al., 2001).
TJs are composed of membrane proteins and a cytoplasmic
plaque consisting of many different proteins that interact
among themselves and interconnect the transmembrane
proteins to form large complexes (Cereijido et al., 2000;
Tsukita et al., 2001; D’Atri and Citi, 2002). The junctional
plaque is formed by different types of proteins that include
adapters, such as the ZO proteins, and signaling components,
such as small GTPases. The membrane proteins mediate cell
adhesion and are thought to constitute the intramembrane
and paracellular diffusion barriers. Although it is well known
that paracellular diffusion across TJs is size and charge selective
and some of the transmembrane proteins have been linked
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to such processes, the molecular mechanisms responsible for
selective paracellular diffusion have not been elucidated but
are thought to involve channels or pores embedded into TJ
strands (Claude, 1978; Cereijido et al., 1989; Balda and
Matter, 2000b; Anderson, 2001; Tsukita et al., 2001).
The actin cytoskeleton plays a crucial role in the regula-
tion of TJs by mechanisms that involve regulation of corti-
cal actin contraction and direct interactions between the
actin cytoskeleton and certain TJ components such as oc-
cludin, cingulin, and the ZO proteins (Hirokawa and Til-
ney, 1982; Meza et al., 1982; Madara, 1987; Hecht et al.,
1996; Blum et al., 1997; Itoh et al., 1997; Tsukamoto and
Nigam, 1997; Turner et al., 1997; Fanning and Anderson,
1998; Cordenonsi et al., 1999; Itoh et al., 1999; Wittchen
et al., 1999; Mattagajasingh et al., 2000; Takakuwa et al.,
2000; D’Atri and Citi, 2001; Lawrence et al., 2002; Patrie
Figure 1. Subcellular localization of 
the B4/7 antigen. (A and B) MDCK cells 
cultured on polycarbonate filters for 5 d 
were fixed with methanol and stained with 
mAb B4/7 (A1 and B1) and polyclonal 
anti–ZO-1 (A2 and B2) antibodies. 
Shown are confocal xy (A) and xz (B) 
sections. A3 and B3 show overlays of 
the two labelings (B4/7, FITC; anti-ZO-1, 
Texas red). Bars, 5  m. (C and D) Ultrathin 
cryosections of MDCK cells were labeled 
with B4/7 followed by a rabbit anti–mouse 
and 5 nm protein A conjugated to 
colloidal gold (C, apical region of a cell; 
D, larger magnification of a TJ). The 
arrows indicate the position of TJs. 
Bars: (C) 150 nm; (D) 100 nm.
Figure 2. Immunostaining of the B4/7 
antigen in mouse blastocysts. Embryos 
were collected and cultured for up to 2 d 
to the blastocyst stage before removal 
of the zona pellucida, fixation in 1% 
formaldehyde, and double staining with 
mAb B4/7 (A1, B1, and C1) and  -catenin 
(A2) or ZO-1 (B2 and C2). A3, B, 3 and 
C3 are overlays of the two labelings. In 
A and C, midplane optical sections 
through the trophectoderm wall of the 
spherical blastocyst are shown, whereas 
in B, a tangential plane is shown. Arrows 
in A indicate distinct sites of B4/7 and 
 -catenin. Bar, 20  m.T
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pression library, resulting in the isolation of the 3
 
 
 
 end of a
partial ORF, which was then completed by rescreening the
library with a PCR protocol and finally by 5
 
 
 
 RACE.
Fig. 3 B shows a schematic drawing of the domain struc-
ture of the B4/7 antigen. The ORF contains 985 aa with a
22-aa alternatively spliced domain close to the COOH ter-
minus. To verify the cloned sequence, we generated anti-
bodies against peptides representing either one of the ter-
mini or the alternatively spliced domain. All three antibodies
immunoblotted the 110-kD band immunoprecipitated by
mAb B4/7 (Fig. 2 C) and labeled cell–cell junctions by im-
munofluorescence (see below), confirming that the cloned
cDNA indeed represents the B4/7 antigen. By RT-PCR, the
isoform containing the insert is the predominant one in
MDCK cells (unpublished data). No isoforms in addition to
the two variants shown in Fig. 3 B were detected by immu-
noblotting with the above described antibodies and by RT-
PCR of different regions of the cDNA.
Blast and PFAM searches suggested that the cloned pro-
tein contains a Dbl homology (DH) and a pleckstrin ho-
et al., 2002). Rho family GTPases are central regulators of
the cytoskeleton (Hall, 1998); consequently, much effort
has been put into analyzing their role in TJ assembly and
function (Nusrat et al., 1995; Takaishi et al., 1997; Zhong
et al., 1997; Jou et al., 1998; Hasegawa et al., 1999; Woj-
ciak-Stothard et al., 2001). Interestingly, the effect of Rho
activation on TJs covers a wide spectrum of effects and ap-
pears to depend on the extent of activation. For example,
overexpression of constitutively active RhoA was shown to
cause structural and functional defects (Jou et al., 1998), but
Rho stimulation via a transfected prostaglandin receptor re-
sulted in a selective increase in paracellular diffusion of a
small molecular weight tracer without a loss of transepithe-
lial electrical resistance (TER) (Hasegawa et al., 1999). Al-
though these studies revealed that Rho and Rac1 regulate
TJs, little is known about TJ-related mechanisms that gov-
ern activation of these GTPases.
Here we identify a TJ-associated guanine nucleotide ex-
change factor (GEF) for Rho that associates with the apical
junctional complex in cultured and native epithelial cells.
The identified canine GEF (cGEF) is the homologue of hu-
man GEF-H1 and mouse Lfc, two previously identified Rho
GEFs shown to associate with microtubules in transiently
transfected nonpolarized cells. Endogenous cGEF-H1 does
not bind microtubules in interphase cells but associates with
the mitotic spindle during cell division. Using overexpres-
sion and RNA interference, we further demonstrate that this
GEF functions in the regulation of selective paracellular per-
meability in MDCK cells. Thus, GEF-H1/Lfc is a func-
tional component of epithelial TJs.
 
Results
 
Identification of a TJ-associated Dbl family member
 
mAb B4/7 stains cell–cell junctions of MDCK cells by im-
munofluorescence microscopy. Confocal xy and xz sections
demonstrated that the B4/7 antigen colocalizes with the TJ
marker ZO-1 at the apical end of the lateral membrane, sug-
gesting that it associates with TJs (Fig. 1, A and B). In xz
sections, the staining for the B4/7 antigen was slightly less
focal than for ZO-1 (Fig. 1, B1 compared with B2). In addi-
tion to cell–cell junctions, weak intracellular staining was
observed. Immuno-EM of frozen sections confirmed the as-
sociation of the B4/7 antigen with TJs (Fig. 1, C and D).
These observations demonstrate that mAb B4/7 recognizes a
TJ-associated protein in MDCK cells. Similar observations
were made when the human intestinal epithelial cell line
Caco-2 was analyzed (unpublished data).
mAb B4/7 also stains a protein associated with apical in-
tercellular junctions in the trophectoderm of the mouse blas-
tocyst. The antigen was found to localize apical to the adhe-
rens junctions identified by 
 
 
 
-catenin staining (Fig. 2 A)
and to colocalize with the TJ marker ZO-1 (Fig. 2, B and
C). In addition to the junctional fluorescence, there was oc-
casionally weak cytoplasmic staining similar to the one seen
in MDCK cells. These data suggest that the B4/7 antigen
also associates with TJs of a native epithelium.
mAb B4/7 labels a protein of 110 kD in immunoblots of
total MDCK cell extracts, which it also immunoprecipitates
(Fig. 3 A). We next used the mAb to screen an MDCK ex-
Figure 3. Molecular identification of the B4/7 antigen. (A) Total 
MDCK cell extracts or an immunoprecipitate generated with mAb B4/7 
were separated on a 5–15% SDS-PAGE gel and then immunoblotted 
with B4/7. The asterisk marks the IgG heavy chain. (B) Domain 
structure of cGEF-H1. Domains identified by PFAM (sequence data 
available from GenBank/EMBL/DDBJ under accession no. AF494096/
AF494097) are shown. (C) B4/7 immunoprecipitates were immuno-
blotted with antipeptide antibodies generated against both cGEF-H1 
termini, the alternative domain, or a control antibody.T
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mology (PH) domain in tandem, a characteristic of the
Dbl family of GEFs for Rho GTPases (Whitehead et al.,
1997). The searches further predicted an NH
 
2
 
-terminal C1
domain. The isolated ORF is homologous to two previ-
ously identified Dbl family members, mouse Lfc and hu-
man GEF-H1, that both possess the same domain struc-
ture. An oncogenic variant of mouse Lfc was cloned in a
screen for proteins that induces oncogenic transformation
and functions as a GEF for Rho (Whitehead et al., 1995;
Glaven et al., 1996). Human GEF-H1 has the same do-
main structure and is known to activate Rho (Ren et al.,
1998; Krendel et al., 2002).
Both GEF-H1 and Lfc had originally been identified as
smaller proteins that lacked much of the domain COOH-
terminal to the PH domain. However, Krendel et al. (2002)
recently described a longer version of GEF-H1 (sequence
data available from GenBank/EMBL/DDBJ under accession
no. AF486838) that is 
 
 
 
90% identical to the here described
canine protein. A homologous sequence of identical length
of mouse Lfc (sequence data available from GenBank/
EMBL/DDBJ under accession no. AF177032) has been de-
posited in GenBank. Since several of the earlier reported
truncated sequences were cloned from transformed cells
and/or were identified because of their transforming poten-
tial, the truncated forms appear to represent oncogenic vari-
ants. Human GEF-H1 and mouse Lfc have previously been
concluded to represent homologues (Krendel et al., 2002).
Since the high degree of similarity suggested that the three
proteins represent homologues, we used Blast searches of the
human genome to test whether they map to the same locus.
These searches revealed that the cloned canine sequence and
mouse Lfc have the highest homology to the gene of GEF-
H1 on human chromosome 1. Similarly, all three proteins
mapped to the same locus when the mouse genome was
searched. Because of these homologies and the experiments
described below, we concluded that the three GEFs indeed
represent homologues; hence, we call the here cloned the
protein cGEF-H1.
 
Localization of GEF-H1 to the actin cytoskeleton 
and microtubules
 
Tagged versions of Lfc and GEF-H1 were demonstrated to
associate with microtubules in nonpolarized cells (Ren et al.,
1998; Glaven et al., 1999; Krendel et al., 2002). To deter-
mine whether this is also the case for the cloned cGEF, we
constructed cDNAs with an NH
 
2
 
-terminal HA epitope
(HA-cGEF-H1). Fig. 4 A shows that HA-cGEF-H1 was
found at cell–cell junctions in transiently transfected
MDCK cells at low expression levels. Additionally, there was
some cytoplasmic fluorescence that became stronger with in-
creasing expression. Non-tagged cGEF-H1 was localizing
more efficiently to TJs (see below), suggesting that the tag
interferes with normal localization. We could not detect a
difference in localization between constructs with and with-
out the alternatively spliced domain (unpublished data).
However, at high expression levels HA-cGEF-H1 was found
to associate with filaments (Fig. 4 B). These filaments were
labeled with anti–
 
 
 
-tubulin antibodies, indicating that they
Figure 4. cGEF-H1 associates with intercellular 
junctions and microtubules in MDCK cells. 
(A) MDCK cells were transiently transfected 
with HA-tagged cGEF-H1. After 3 d the cells 
were permeabilized, fixed, and labeled with 
anti-HA antibodies. Bar, 5  m. (B and C) Low 
confluent MDCK cells transiently transfected 
with HA-cGEF-H1 were fixed with methanol 
and labeled with anti-HA and anti– -tubulin 
antibodies. B shows the anti-HA staining of 
a strongly expressing cell, and C is a larger 
magnification of a peripheral region of the cell 
shown in B (C1, anti-HA; C2, anti– -tubulin). 
Bars: (B) 5  m; (C) 2  m. (D) Transiently 
transfected cells were processed as in C. Cells 
with a moderate expression level (D1, anti-HA; 
D2, anti– -tubulin; D3, DNA) are shown. Bar, 
5  m. (E and F) High density wild-type MDCK 
cells were stained with a peptide antibody 
against the NH2 terminus of cGEF-H1 (E1) and 
an mAb specific for ZO-1 (E2). Bar, 3  m. 
(F) Low confluent MDCK cells were stained 
with antibodies against the NH2 terminus of 
cGEF-H1(F1) and anti– -tubulin (F2). Bar, 3  m. 
(G) Low confluent MDCK cells were extracted 
with Triton X-100 in the presence of Taxol 
before fixation and then processed for immuno-
fluorescence with mAb B4/7. G1 and G2 show 
two serial sections of the same cell. Note, a 
fraction of cGEF-H1 remained associated with 
junctions during mitosis. Bar, 3  m.T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
C
e
l
l
 
B
i
o
l
o
g
y
 
 
 
A tight junction–associated Rho activator |
 
 Benais-Pont et al. 733
 
are microtubules (Fig. 4 C). Fig. 4 D shows that clear micro-
tubule association was not observed at low expression levels
in interphase cells but was pronounced in mitotic cells in
which the transfected protein was found at the mitotic spin-
dle. Thus, transfected epitope-tagged cGEF-H1 can asso-
ciate with microtubules similar to human GEF-H1 and
mouse Lfc.
Given these observations, it was surprising that endoge-
nous cGEF-H1 was associated with TJs in interphase cells
since microtubules are not detected close to intercellular
junctions. Additionally, the distribution of endogenous
cGEF-H1 was not affected by the depolymerization of mi-
crotubules with nocodazole, indicating that the junctional
association does not depend on microtubules (unpublished
data). Nevertheless, the above described observations sug-
gest that cGEF-H1 may associate with microtubules under
certain conditions such as mitosis. To test this, we used the
above described antibodies to test whether endogenous
GEF-H1 can be detected at the mitotic spindle. Fig. 4 E
shows that the antibody generated against the NH
 
2
 
 termi-
nus labeled TJs in wild-type MDCK cells. However, in
mitotic cells GEF-H1 was found to concentrate at the mi-
totic spindle (Fig. 4 F). Similar observations were made
with the antibodies specific for the COOH terminus and
the alternatively spliced domain (unpublished data). mAb
B4/7 stained the mitotic spindle inefficiently and only af-
ter Triton X-100 extraction, suggesting that the epitope
recognized by the mAb is blocked when cGEF-H1 is asso-
ciated with microtubules (Fig. 4 G). Junctional GEF stain-
ing in mitotic cells often appeared heterogeneous, which
might be caused by the recruitment of a fraction of junc-
tional cGEF-H1 to mitotic spindles. These data indicate
that endogenous cGEF-H1 is concentrated at TJs in inter-
phase cells but also associates with spindle microtubules
during mitosis.
We next used the human fibroblast cell line MRC-5 to
test whether association of endogenous GEF-H1 with non-
Figure 5. cGEF-H1 associates with different actin-based cytoskeletal 
structures in different cell types. Low confluent MRC-5 fibroblasts (A), 
MDCK (B), and Caco-2 (C) cells were fixed with PFA, permeabilized 
with Triton X-100, and fluorescently labeled with B4/7 (A1, B1, and 
C1) and TRITC-phalloidin (A2, B2, and C2). Bars, 6  m.
Figure 6. Activation of Rho by cGEF-H1. (A) Total cell extracts of 
wild-type (wt) or transfected MDCK cells were immunoblotted with 
mAb B4/7. 3A3 and 3A4, clones overexpressing cGEF-H1; control, 
clone derived from control transfection. (B) Wild-type and transfected 
MDCK cells expressing truncated cGEF-H1 (HA-GEF-T) or wild-type 
cGEF-H1 were extracted and tested for the presence of activated 
Rho or Rac1 by performing pull-down assays with recombinant 
fusion proteins lacking (GST) or containing a GTPase-binding 
domains of (GST-GBD). The pulled-down fractions were analyzed 
by immunoblotting for the presence of Rho or Rac1. Increasing 
amounts of total cell extracts were loaded on the gels to normalize 
the amount of GTPases in different cell extracts (1X Total ex and 2X 
Total ex). Immunoblots were quantified by densitometric scanning, 
and the values obtained for the activated GTPase were divided by 
those obtained in total cell extracts. All ratios were then normalized 
to wild-type cells and expressed as fold activation (mean   SD of 
three experiments; both increases in active Rho are significant, 
p   0.05 using the Student’s t test).T
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microtubule-based structures can also be observed in nonpo-
larized cells. Fig. 5 A shows that endogenous GEF-H1 was
found to associate with filaments that were stained with
phalloidin, indicating that they are actin filaments. Interest-
ingly, stress fibers were not stained by anti–GEF-H1 anti-
bodies in low confluent MDCK cells but the labeling coin-
cided with the F-actin staining at cell–cell junctions (Fig. 5
B). Similarly, endogenous GEF-H1 colocalized with F-actin
at cell–cell junctions and not at stress fibers in the human in-
testinal epithelial cell line Caco-2 (Fig. 5 C). This suggests
that GEF-H1 can localize to different types of actin-based
structures in different cell types.
 
Overexpression of cGEF-H1 results in Rho activation
 
Human GEF-H1 and mouse Lfc function as activators of
Rho (Glaven et al., 1996; Krendel et al., 2002). To test
whether cGEF-H1 indeed functions as a GEF for Rho, we
generated cell lines overexpressing either wild-type cGEF-
H1 (Fig. 6 A) or an HA-tagged truncated mutant containing
only the DH and PH domains, a type of mutation that re-
sults in constitutively active variants of Dbl family members.
Activation of Rho was then tested by performing pull-down
assays with GST fusion proteins containing the GTPase-
binding domain of rhotekin; in control experiments, 
 
 
 
PAK
was used to pull down Rac1 as a control, since this GTPase
is not activated by GEF-H1/Lfc (Glaven et al., 1996; Be-
nard et al., 1999; Ren et al., 1999; Nakagawa et al., 2001;
Krendel et al., 2002).
Fig. 6 B shows that overexpression of truncated GEF-H1
(HA-GEF-T) resulted in a more than twofold up-regula-
tion of active Rho, whereas the levels of active Rac were not
affected. The transfected truncated protein accumulated in
the cytosol and expression was paralleled by a large increase
in stress fibers and cell spreading (unpublished data), fur-
ther supporting Rho activation. Overexpression of full-
length cGEF-H1 resulted in an increase in active Rho by
 
 
 
50%, and no changes in the levels of active Rac1 were de-
tected. Overexpression of wild-type cGEF-H1 did not
cause an obvious change in the actin cytoskeleton such as
an increase in stress fibers (unpublished data), suggesting
that Rho activation by the wild-type GEF was spatially
more restricted to TJs.
 
GEF-H1 regulates paracellular permeability of MDCK 
cell monolayers
 
We next tested whether overexpression of cGEF-H1 affects
TJ functions. Since we have thus far not been able to gener-
ate epitope-tagged proteins that accumulate efficiently at TJs
at high expression levels, we used stable cell lines such as
those shown in Fig. 6 A that overexpress wild-type cGEF-
 
Figure 7.
 
Functional analysis of TJs of cells overexpressing cGEF-H1.
 
 
(A) Wild-type (wt) and cGEF-H1–overexpressing (3A4) cells, cultured 
for 1 wk on polycarbonate filters, were fixed and processed for double 
immunofluorescence using mAb B4/7 and anti–ZO-1 antibodies. 
Images obtained with constant microscope sensitivity settings are 
shown. Bar, 10 
 
 
 
m. (B and C) MDCK cells were cultured on filters 
for 1 wk and were then analyzed first by measuring TER (B) and, after 
a time of recovery, by determining paracellular permeability of 4 kD 
FITC-dextran (C) or 400 kD FITC-dextran (D). At the end, the cultures 
were analyzed for overexpression of cGEF-H1 by immunoblotting 
(examples are shown in Fig. 3 A). All values of transfected cells 
represent means 
 
 
 
 SD of several independent clones: four clones 
were analyzed for cGEF-H1
 
 
 
I, three clones for cGEF-H1-I, and 
three control clones that were derived from a transfection of the 
empty vector. The increases in 4 kD FITC-dextran permeability of 
overexpressing cells are significant (cGEF-H1
 
 
 
I, p 
 
  
 
0.02 and 
cGEF-H1-I, p 
 
  
 
0.05 using the Student’s 
 
t
 
 test) (E) Fluid phase 
transcytosis was measured after labeling cells for 10 min at 37
 
 
 
C 
with HRP from the apical side. Cells were then cooled on ice and 
extensively washed. Transcytosis was then allowed to proceed for
2 h at 37
 
 
 
C. Basolateral media were then collected, and transcy-
tosed HRP was measured. Averages obtained from two different 
clones for each type of transfection are shown.T
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H1 at least fivefold to avoid artifacts induced by the epitope
tags. Immunofluorescence of filter-grown cells demonstrated
that overexpressed cGEF-H1 accumulated efficiently at TJs
and that the cells formed apparently normal monolayers
(Fig. 7 A). At the immunofluorescence level, neither the dis-
tribution of ZO-1 (Fig. 7 A) nor of the transmembrane pro-
teins occludin and claudin-4 (unpublished data) was affected
by cGEF-H1 overexpression. Furthermore, staining with
fluorescent phalloidin did not reveal changes in the distribu-
tion of F-actin (unpublished data).
To determine whether cGEF-H1–overexpressing cells
still formed electrically tight monolayers, we measured
TER. Fig. 7 B shows that TER was not altered by cGEF-
H1 overexpression, supporting the conclusion that mono-
layer formation was not affected. In contrast, paracellular
Figure 8. Freeze-fracture analysis of TJs. (A) MDCK cells were 
fixed and processed for freeze-fracture. Images of wild-type cells 
and cells overexpressing cGEF-H1-I and cGEF-H1 I, respectively, 
are shown. Bar, 150 nm. (B). Images obtained from freeze-fracture 
replicas were quantified over a total distance of 44.2  m for wild-
type cells, 28.0  m for cGEF-H1-I, and 50.8  m for cGEF-H1 I–
overexpressing cells. The total number of segments counted for 
each cell line was set to 100%.
 
permeability of 4 kD FITC-dextran was found to be four-
to fivefold up-regulated in cells overexpressing either one
of the two identified isoforms (Fig. 7 C). Similar results
were obtained when permeability of tritiated mannitol was
measured (unpublished data). In contrast, paracellular per-
meability of 400 kD FITC-dextran was not affected, indi-
cating that the increase was specific for small molecular
weight tracers (Fig. 7 D). Overexpression of cGEF-H1 did
not affect transcytosis of HRP, indicating that the increase
in 4 kD FITC-dextran permeability was not due to in-
creased fluid phase transcytosis (Fig. 7 E). These data sug-
gest that cGEF-H1 functions in the regulation of paracel-
lular permeability.
In freeze-fracture replicas, TJs appear as a characteristic
network of intramembrane strands. The integrity of this
network is generally taken as evidence for correct assembly
of TJs. Therefore, we next analyzed the appearance of TJs
in wild-type and cGEF-H1–overexpressing cells by freeze-
fracture. Fig. 8 A shows that overexpression did not inhibit
the formation of intramembrane strands. Quantification of
the number of strands revealed that overexpression of nei-
ther of the two isoforms resulted in a reduction of the
number of strands (Fig. 8 B). This further supports the
conclusion that overexpression of cGEF-H1 did not result
in increased paracellular permeability because of a defect in
TJ assembly.
To test the relevance of endogenous cGEF-H1 in the reg-
ulation of paracellular permeability, we used RNA interfer-
ence to reduce expression of the endogenous protein. Stable
cell lines were generated that expressed short RNA duplexes
directed against either one of two different regions of cGEF-
H1 (GEF-RD-I and GEF-RD-II). Expression was then
compared with cells transfected with a plasmid driving the
expression of a control RNA duplex with a random sequence
(control-RD). Immunoblotting demonstrated that expres-
sion of cGEF-H1 could be significantly reduced by expres-
sion of either one of the two cGEF-H1–directed RNA du-
plexes (Fig. 9 A), and immunofluorescence with mAb B4/7
revealed that both junctional and cytoplasmic fluorescence
were reduced (Fig. 9 B).
We next analyzed the effects of reduced expression of
cGEF-H1 on TJ functions. Fig. 9 C shows that TER was
not affected by the reduced expression of cGEF-H1. In con-
trast, paracellular permeability of 4 kD FITC-dextran was
reduced by 
 
 
 
50% in cells expressing cGEF-H1–directed
RNA duplexes in comparison to wild-type MDCK cells and
control transfections (Fig. 9 D). These data further support
the conclusion that cGEF-H1 functions in the regulation of
paracellular permeability.
 
Discussion
 
RhoA is an important regulator of TJ, but regulators of Rho
that localize to TJs have not been identified previously.
Here, we describe the identification of a Dbl family member
as a novel functional component of TJs that associates with
this intercellular junction in cultured and native epithelia.
This junctional GEF is the canine homologue of human
GEF-H1 and mouse Lfc. This protein activates Rho and
regulates paracellular permeability of small hydrophilic trac-T
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ers. Increased permeability was not associated with a break-
down of the junctional barrier as determined morphologi-
cally and by measuring TER and permeability of a high
molecular weight tracer. Given the importance of Rho in the
regulation of paracellular permeability (Hecht et al., 1996;
Turner et al., 1997; Fujita et al., 2000; Hirase et al., 2001),
this suggests that this TJ-associated GEF is part of a Rho-
based permeability-regulating pathway.
 
Identification of cGEF-H1
 
Molecular cloning of the antigen recognized by mAb B4/7
resulted in the isolation of a canine cDNA that is 
 
 
 
90%
identical with human GEF-H1 and its mouse homologue
Lfc, which share a similar degree of homology with each
other, suggesting that we have isolated the canine homo-
logue of GEF-H1/Lfc. This is supported by the observa-
tion that the three proteins match best to the same gene in
the human and the mouse genome. Furthermore, trans-
fected epitope-tagged cGEF-H1 accumulates at microtubules,
which was also observed for human GEF-H1 and mouse
Lfc. Additionally, antipeptide antibodies against sequences
that are identical in the three GEFs recognize TJs in canine
and human epithelial cells.
It was surprising to find a protein known to associate with
microtubules on TJs, which are linked to the actin cytoskel-
eton and not microtubules (Hirokawa and Tilney, 1982;
Meza et al., 1982; Madara, 1987; Fanning, 2001). How-
ever, immunofluorescence in different cell types indicated
that endogenous GEF-H1 can localize to different actin-
based structures such as the TJs in epithelial cells and stress
fibers in a fibroblast cell line. Moreover, endogenous GEF-
H1 was found to concentrate at mitotic spindles, indicating
that GEF-H1 can associate with both the actin cytoskeleton
and microtubules.
We have not observed a clear microtubule staining (with
antibodies that were raised against sequences identical in ca-
nine and human GEF-H1 and mouse Lfc) in nontransfected
interphase cells using several epithelial and nonepithelial cell
lines (e.g., MDCK, Caco-2, HeLa, MRC-5, and 3T3). In
low confluent cells, we observed fine intracellular dots that
occasionally aligned along microtubules (unpublished data).
However, the significance of this observation is not clear,
since only a fraction of these dots were close to microtu-
bules. Since our antibodies are able to detect GEF-H1 on
mitotic spindles, the absence of microtubule staining in in-
terphase cells is unlikely to be due to problems with epitope
accessibility but may rather reflect a yet to be identified reg-
ulatory mechanism that controls the differential subcellular
localization of GEF-H1 in interphase and mitotic cells.
Since GEF-H1 is a phosphoprotein and its phosphorylation
depends on the proliferation state in MDCK cells (unpub-
lished data), it could be that localization of GEF-H1 is regu-
lated by protein phosphorylation.
 
Figure 9.
 
Analysis of MDCK cells with reduced expression of 
GEF-H1.
 
 (A) MDCK cells transfected with a plasmid driving the 
expression of a control RNA duplex (control-RD c1) or RNA duplex 
targeting different regions of cGEF-H1 (GEF-RD-I c6 and GEF-RD-II c4) 
were harvested, and expression was analyzed by immunoblotting 
with mAb B4/7. ZO-1 and 
 
 
 
-tubulin were immunoblotted as controls. 
The reduction of GEF-H1 expression in all clones used for the 
functional analysis was at least 50%. (B–D) MDCK cells were cultured 
on filters for 9 d and were then analyzed by immunofluorescence 
(B shows labelings with mAb B4/7 and a polyclonal anti–ZO-1 
antibody; Bar, 8 
 
 
 
m), by measuring TER (C), and by determining 
paracellular permeability of 4 kD FITC-dextran (D). The values 
represent means 
 
 
 
 SD of four clones for cells with reduced cGEF-H1 
expression (GEF-RD) and two clones for control transfections 
(control-RD). The decrease in paracellular permeability of GEF-RD 
cells is significant (p 
 
 
 
0.01 using the Student’s 
 
t
 
 test).T
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GEF-H1 and the regulation of paracellular permeability
 
Increased permeability by cGEF-H1 overexpression did not
result in a disruption of TJ strands, suggesting that cGEF-
H1 overexpression activated a mechanism that either regu-
lates or mediates selective paracellular permeability (Balda
and Matter, 2000b; Cereijido et al., 2000; Tsukita et al.,
2001). Given our limited understanding of the mechanisms
mediating selective paracellular permeability, it is not clear
whether this involves modifications of the junctional actin
cytoskeleton or changes in the activities of components of
TJ strands such as claudins or occludin.
Activation of Rho has been linked previously to regulation
of TJ structure and function (Nusrat et al., 1995; Takaishi et
al., 1997; Zhong et al., 1997; Jou et al., 1998; Hasegawa et
al., 1999; Hirase et al., 2001; Wojciak-Stothard et al., 2001).
Although overexpression of constitutively active or domi-
nant-negative RhoA was shown to result in striking morpho-
logical alterations, such as a loss of the normal TJ strand mor-
phology (Jou et al., 1998), activation of endogenous Rho was
linked to selective functional changes without obvious effects
on TJ structure. Hasegawa et al. (1999) demonstrated that
activation of Rho in MDCK cells via a transfected prosta-
glandin receptor results in a selective increase in paracellular
permeability of small molecular weight tracers. It will be in-
teresting to test whether cGEF-H1 becomes activated by this
prostaglandin receptor. However, since prostaglandin treat-
ment was paralleled by increased TER, although in our study
TER was not affected by increases or decreases in cGEF-H1
expression, these two proteins may be part of different regula-
tory pathways. Alternatively, prostaglandin receptors may ac-
tivate more than one pathway: one regulating paracellular
permeability and another one ion conductivity.
Regulation of TJs by Rho is likely to involve different
pathways and varies with the cell type analyzed. Several stud-
ies linked the Rho effector ROCKI to the regulation of TJ
assembly and paracellular permeability. This pathway is
thought to modify TJs by regulating myosin phosphoryla-
tion and hence contraction of the cortical actin cytoskeleton.
Depending on the conditions and/or cell type analyzed, acti-
vation of ROCKI was linked to TJ assembly and increases in
TER or to junction disassembly and increased permeability
(Gopalakrishnan et al., 1998; Fujita et al., 2000; Hirase et
al., 2001; Walsh et al., 2001; Wojciak-Stothard et al.,
2001). In our experiments, treatment with the ROCKI in-
hibitor Y27632 resulted in a loss of the paracellular barrier
(unpublished data). Given these observations, it is possible
that integrity of TJs and regulation of paracellular perme-
ability requires a balance between different Rho effector
pathways. This is supported by the recent observation that
ROCKI and DiaI represent opposing Rho effector pathways
that regulate adherens junction formation and dynamics
(Sahai and Marshall, 2002). Additionally, different stimuli
that cause activation of Rho can result in increases in endo-
thelial permeability via a ROCKI-dependent or -independent
pathway, suggesting that at least two different Rho pathways
regulate paracellular permeability (Hirase et al., 2001).
 
Possible additional functions of GEF-H1
 
In addition to paracellular permeability, GEF-H1 may be in-
volved in other Rho-regulated processes. For example, GEF-
H1 may participate in events that require rearrangements of
intercellular junctions. In endothelia, leukocyte transmigra-
tion requires Rho activation (Adamson et al., 1999). There-
fore, GEF-H1 may become activated during transmigration
to stimulate the required cytoskeletal rearrangements.
It has been demonstrated recently that apoptotic cells are
extruded by their neighbors in MDCK monolayers (Rosen-
blatt et al., 2001). This process requires stimulation of Rho
and contraction of the cortical actin cytoskeleton. Although
it is not know how apoptotic cells signal to their neighbors,
it could be that this involves activation of Rho by the TJ-
associated GEF-H1.
In addition to regulating processes occurring at TJ,
cGEF-H1 may also function in the regulation of epithelial
cell proliferation and differentiation. RhoA and Rac1 are
regulated in opposite ways: Rac1 is up-regulated and RhoA
down-regulated when cells reach full confluence and assem-
ble cell–cell junctions, whereas Ras transformation causes
Rac1 inactivation and RhoA activation (Zondag et al.,
2000; Fukata and Kaibuchi, 2001). Hence, TJs may help to
control RhoA activity by recruiting cGEF-H1 to TJs in ma-
ture monolayers and, in the absence of a stimulus, inactivat-
ing its GEF activity.
Since GEF-H1 associates with the mitotic spindle, it
could be that it participates in the regulation of cell division.
Cytokinesis is a Rho-dependent process, suggesting that
GEF-H1 could be important to complete the cell cycle
(Glotzer, 2001). Strikingly, microtubule-associated GEF-
H1 becomes activated when microtubules are depolymer-
ized by nocodazole in transfected cells (Krendel et al., 2002).
Hence, it could be that depolymerization of spindle micro-
tubules during cytokinesis activates GEF-H1, and subse-
quently Rho, resulting in cytokinesis and assembly of inter-
cellular junctions between the two daughter cells.
These are interesting possible functions for GEF-H1, and
their study may lead to the identification of novel mecha-
nisms by which TJs can participate in the regulation of di-
verse cellular functions. It will also be important to identify
interacting proteins in order to understand how GEF-H1
can associate with microtubules and the actin cytoskeleton
and how these processes are regulated. Moreover, the associ-
ation with stress fibers in fibroblasts, but TJs in epithelial
cells suggests that different interacting proteins may func-
tion as linkers to the actin cytoskeleton in different cell
types. Information about interacting partners may ulti-
mately also help us to understand how GEF-H1 becomes ac-
tivated in different subcellular locations and triggers activa-
tion of Rho.
 
Materials and methods
 
Antibodies
 
mAb B4/7 was derived from a mouse immunized with a protein fraction
isolated from detergent extracts of MDCK cells using fusion proteins con-
taining the cytoplasmic domain of low density lipoprotein receptor. Bind-
ing of GEF-H1 to this fusion protein was not specific. Hybridoma produc-
tion and subcloning were as described (Hauri et al., 1985). Five subclones
of the originally isolated hybridoma line were isolated and found to recog-
nize all the same protein in immunoblots and to produce the same pattern
in immunofluorescence experiments.
All peptides and antipeptide antibodies were produced by Gramsch
Laboratories. The following peptides were used to generate rabbit poly-
clonal antibodies: anti–cGEF-H1 NH
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 terminus, MSRIESLTRARTERC; anti–T
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cGEF-H1 COOH terminus, CDFTRMQDIPEETES; anti–cGEF-H1 alterna-
tive domain, CRGHDRLDLSVTIRSVH; anti–ZO-1, YTDQELDETLNDEVC;
and anti–claudin-4, PRTDKPYSAKYSAAC. The peptides were conjugated
to epoxy-activated Sepharose (Amersham Biosciences), and the antibodies
were affinity purified as described (Balda et al., 1996). For 
 
 
 
-tubulin, mAb
1A2 was used (Kreis, 1987), and in some immunofluorescence experi-
ments ZO-1 was detected with rat monoclonal R40.76 (Anderson et al.,
1988) or with a rabbit polyclonal antibody (Sheth et al., 1997). 
 
 
 
-Catenin
was detected with the M12K rabbit polyclonal antibody (Herrenknecht et
al., 1991). GTPases were detected by immunoblotting using the following
anti-GTPase antibodies: Rho, rabbit polyclonal antibody sc-179 anti-RhoA
(Santa Cruz Biotechnology, Inc.) and Rac1, mouse mAb 102 (BD Trans-
duction Laboratories).
 
Cloning of canine GEF-H1/Lfc and generation of stable cell lines
 
mAb B4/7 was used to screen pTEX-based MDCK expression libraries
(Herz et al., 1990; Balda and Matter, 2000a). The 5
 
 
 
 end was cloned by
PCR screening (Takumi and Lodish, 1994) and 5
 
 
 
 RACE (FirstChoice
 
TM
 
RLM RACE kit; Ambion). For sequence analysis and homology searches,
we used ClustalW, Pfam, and the Blast search of the Ensembl Genome
Browser with the human genome database.
The cDNAs coding for the full-length protein with or without the alter-
native domain were then assembled in the cytomegalovirus-based expres-
sion vector pCB6 for stable expression. HA-tagged truncated GEF-H1 (HA-
GEF-T) containing the DH and the PH domain was generated by PCR and
cloned into pCB6 containing the HA epitope (Balda et al., 1996). Stably
transfected MDCK cell lines were generated as described previously
(Balda et al., 1996).
The mU6pro vector was used for the expression of RNA duplexes (Yu et
al., 2002). Two regions of canine GEF-H1 were targeted that are part of se-
quences coding for different protein domains (region I, 5
 
 
 
-AACAAGAG-
CATCACAGCCAAG-3
 
  
 
and region II, 5
 
 
 
-AATGTGACTATCCACAACCGC-
3
 
 
 
). Derivatives of the mU6pro vector were constructed as described (Yu et
al., 2002) and cotransfected with a plasmid carrying a puromycin resis-
tance gene for the selection of stable cell lines.
Several clones were analyzed for each type of transfection: three clones
for cGEF-H1 with the alternatively spliced domain, three clones for cGEF-
H1 lacking the alternatively spliced domain, three control clones that were
derived from a transfection of the empty vector, four clones expressing
cGEF-H1–directed RNA duplexes, and two clones expressing control RNA
duplexes with a random sequence.
 
Analysis of TJ functions, transcytosis, pull-down assays, 
and immunoblots
 
Wild-type and transfected MDCK cells were plated on 12-well Transwell
Filters and cultured for at least 7 d before the paracellular permeability
measurements (Balda et al., 1996). After this time of culture, all transfected
cell lines exhibited stable TER values that did not significantly change any-
more from one day to the other. TER and paracellular flux of FITC-dextran
(4 and 400 kD) were measured as described (Balda et al., 1996).
To measure fluid–phase transcytosis, cells grown on filters were allowed
to take up HRP (10 mg/ml) for 10 min at 37
 
 
 
C. Internalization was stopped
by cooling the cells on ice, and the cells were then washed six times for 3
min with cold PBS containing 0.5% BSA. The cultures were incubated
again at 37
 
 
 
C for 120 min, and the media were collected and transcytosed
HRP was measured with a colorimetric assay (Matter et al., 1994).
Plasmids for GST fusion proteins containing GTPase-binding domains
were produced as described (Ren et al., 1999; Nakagawa et al., 2001). Fu-
sion proteins were stored at –80
 
 
 
C for a maximum of 2 wk. For pull-down
assays, cells were grown in 15-cm tissue culture plates. Cells were ex-
tracted, and active GTPases were pulled down as described (Ren et al.,
1999; Nakagawa et al., 2001). Immunoblotting was done as described pre-
viously using HRP-conjugated secondary antibodies and the ECL chemilu-
minescence detection system (Amersham Biosciences).
 
Microscopy
For immunofluorescence, the cultured cells were either fixed with metha-
nol at –20 C without preextraction or permeabilized and fixed with Triton
X-100 and 3% PFA (Balda et al., 1996). Filter-grown cells were fixed and
permeabilized with ethanol/acetone or with methanol at –20 C (Balda et
al., 1996). To stain mitotic spindles with mAb B4/7, cells were extracted
with 0.2% Triton X-100 in 100 mM KCl, 3 mM MgCl2, 1 mM CaCl2, 200
mM sucrose, and 10 mM Hepes (pH 7.1) on ice in the presence of 10  M
Taxol before fixation with methanol. The samples were incubated with an-
tibodies and mounted as described previously (Balda et al., 2000). DNA
was stained with TO-PRO-3 (Molecular Probes). Fluorescent secondary
antibodies were obtained from Molecular Probes or Jackson ImmunoRe-
search Laboratories, Inc.
For immunolocalization experiments in mouse blastocysts, preimplan-
tation embryos were collected from superovulated and mated MF1 female
mice and cultured in T6 medium with BSA to the blastocyst stage as de-
scribed previously (Sheth et al., 2000). Embryos, after removal of the zona
pellucida, were fixed in 1% formaldehyde for 10 min and permeabilized
in 0.25% Triton X-100 before antibody incubations in specialized cham-
bers (Sheth et al., 2000). Secondary antibodies conjugated to fluorescent
Alexa dyes were from Cambridge Bioscience. Embryos were examined
whole mount.
For immuno-EM, MDCK cells were fixed with 3% PFA and then pro-
cessed for cryosectioning and immunolabeling (Liou et al., 1996; Raposo
et al., 1997). Freeze-fracture analysis was performed as described previ-
ously (Balda et al., 1996). The morphometric analysis was performed on
micrographs of freeze-fracture replicas that were printed at 50,000  mag-
nification. Lines parallel to the main axis of the TJ were traced, and series
of perpendicular lines were then drawn (one line every 200 nm). The num-
ber of strands of a given segment of TJs was defined as the number of its in-
tersections with the perpendicular line.
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